Shanghai Kaibao Pharmaceutical CO.,Ltd

¥4.82As of Sun 8 Nov 2026, 12:00 UTC
SZSE:300039Healthcare
Country China
PE (Fwd) •••
TSR 10Y CAGR (3.96%)
Div yield 4.15%
ROE 5.30%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.22
PE TTM 21.45
TSR TTM (20.03%)
Mkt cap ¥5.042B
ROIC 6.09%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥4.72
(2.08%)
56.75%
Hold 8|1|3|0|6
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.08
0.08
0.09
0.09
4.11%
5.24%
13.43%
14.49%
Revenue¥M
554.0
560.5
544.6
539.6
0.21%
(1.75%)
(2.96%)
(2.06%)
Peers (US$755.8M)
Cap (US$)
PE
776.3M
21.45x
752.8M
31.66x
Capital
TTM
5Y
10Y
Leveragex
3.957
0.106
0.106
EBIT/Intx
0.512
0.623
0.601
Own earn%
(17.88)
(89.23)
(81.38)
Sh yield%
20.36
28.67
24.97
Owners
Insiders/Inst%
9.80
50.91
Short interest%
2.10
SBC / revenue%
4.88
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
10
Op margin range%
18–24
$1 testx
0.2
Incr. ROIC%
9